
Explore cutting-edge research on aging biology, disease prevention, and longevity solutions. Learn about innovative approaches to improve health in older populations and investment opportunities in scientific longevity.

Explore the gut microbiome's role in disease prevention and treatment. Learn from experts about its impact on diet, cancer, and overall health, and discover how to harness its power for wellness.

Exploring innovative urban solutions for aging populations, focusing on city planning, infrastructure, and technology to promote healthy, productive, and purposeful aging in urban centers.

Explore cutting-edge insights on brain health, longevity, and Alzheimer's prevention. Leading experts discuss lifestyle factors, emerging therapies, and promising research for maintaining cognitive function as we age.

Explore disruptive healthcare models, from research to delivery, as experts discuss shifting incentives, technological advancements, and emerging investment strategies reshaping the medical landscape.

Experts discuss strategies to extend health span, including personalized medicine, lifestyle changes, and digital health tools, emphasizing the importance of collaboration across sectors for a healthier aging future.

Experts discuss challenges and opportunities in meeting UN Sustainable Development Goals, focusing on global health, economic development, and innovative solutions for financing and implementing massive programs.

Explore genomics, medical devices, and computer science in precision medicine to revolutionize patient care, offering hope for better treatments and cures across all age groups and conditions.

Explore immunotherapy's potential as a revolutionary cancer treatment, its advantages over chemotherapy, and the challenges and opportunities in its development and implementation.

Experts discuss market predictions, economic fallout, and investment opportunities during the pandemic, exploring the disconnect between markets and the current economy.

Explore strategies to combat disinformation through collaboration between the public, regulators, and social media companies, addressing online safety in times of crisis.

Experts discuss Oxfam's report on COVID-19's impact on global inequality, exploring wealth, racial, and gender disparities, and proposing actions to address these pressing issues.

Explore recent microbiology research on antibiotic resistance, foodborne illnesses, Ebola updates, and viral defense mechanisms against CRISPR, offering insights into current challenges and advancements in the field.

Explore the Smithsonian's "Outbreak" exhibit, discussing epidemics, One Health, and global connectivity with experts. Gain insights on curating engaging science exhibitions for public education.

Experts discuss vaccine efficacy, debunk myths, and address public concerns in this informative talk on immunization science, policy, and societal impact.

Explore recent microbiology research on vector-borne diseases, CRISPR diagnostics, influenza sequencing, and gut microbiome. Learn about cutting-edge developments and their potential impact on public health and disease detection.

Explore recent microbiology research on viral evolution, antibiotic resistance, and amphibian diseases. Learn about new antibiotics and global health trends in this informative discussion of current scientific literature.

Explore microbiome impacts of non-antibiotics, AI-driven virus discovery, insights into early life, disease spread on planes, and increased science funding in this comprehensive microbiology update.

Explore FDA standards, GOF policy changes, and Ebola antibodies. Gain insights on hypervirulent Klebsiella pneumoniae, C. difficile virulence, and white-nose syndrome in bats. Stay updated on crucial microbiology developments.

Explore antibiotic development strategies, from hit identification to lead optimization, focusing on key considerations for successful drug candidates in combating antimicrobial resistance.

Explore recent microbiome research on MS, oral health, and cancer therapies. Discover connections between gut bacteria, T cells, and autoimmune symptoms, plus innovative approaches in protein design and viral oncolytics.